Malondong, Maryjean .

HRN: 28-11-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2026
08/18/2026
IV
500 Mg
Q8
PROM , Thickly MSAF
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: